Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Tempus AI
- 入组人数
- 1,000
- 试验地点
- 2
- 主要终点
- Create robust data set of health information
研究概览
简要总结
Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.
详细描述
The Study will collect combined clinical and molecular health information for cancer patients in the United States from multiple academic medical centers and community oncology practices. Participants who agree to join the Study will have their molecular profiling results, associated clinical health information, and longitudinal outcomes health information collected by the participating Institution for submission to Tempus. The specific goal of the Study is to create an outcomes-based dataset for future research to improve cancer treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Solid or hematologic malignancy.
- •Willing and able to provide informed consent where required.
- •Has received or will receive genomic profiling.
排除标准
- •Individuals without the capacity to consent.
- •Prisoners at the time of enrollment.
结局指标
主要结局
Create robust data set of health information
时间窗: Up to 10 years
To create a robust data set of health information about cancer patients who receive comprehensive genomic profiling in order to facilitate future novel precision medicine research
次要结局
- Evaluate longitudinal paired tissue and cell free molecular testing(Up to 10 years)
- Document clinical events for patients who have had comprehensive genomic profiling(Up to 10 years)